Press Releases

NASHVILLE, Tenn., Nov. 11, 2019 /PRNewswire/ -- Lee Beaman is making spirits bright by hosting a toy drive at Beaman Automotive Group beginning November 16 through December 13. Donated gifts will be part of Monroe Carell Jr. Children's Hospital at Vanderbilt's annual "Champ's Ho

STOCKHOLM, Nov. 11, 2019 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced the hiring of Dr. Coenraad Tamse as Vice President, International Sales. Dr. Tamse brings more than 20 years of commercial, marketing, and executive experience in the medic

OSLO, Norway, Nov. 11, 2019 /PRNewswire/ -- Targovax ASA (OSE: TRVX), announces that clinical data from its combination trial with ONCOS-102 and Keytruda in anti-PD1 refractory melanoma was presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting Dr. Shoushtari, MD, Medical Oncologist, Memorial Sloan Kettering, presented results from part

SOUTH PLAINFIELD, N.J., Nov. 11, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced positive results from part 2 of SUNFISH demonstrating that the study met its primary endpoint of change from baseline after 1 year of treatment with risdiplam compared to placebo as measured by the Motor Function Measure 32, a scale monitoring severity

MOUNTAIN VIEW, Calif., Nov. 11, 2019 /PRNewswire/ -- Open enrollment is just kicking off and "survey says": insured Americans aren't impressed. HealthPocket, a free information source designed t

SINGAPORE, Nov. 10, 2019 /PRNewswire/ -- Stone Capital and Biosyngen have partnered to establish a Biopharmaceutical Investment Fund in Singapore, the signing ceremony was held in Ascendas One Hub of China-Singapore Guangzhou Knowledge City. The key investment targets of the biopharmaceutical fund of US$50 mi

STOCKHOLM, Nov. 10, 2019 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) announced today that its indirect wholly owned subsidiary Dragonfly Acquisition Corp. (Dragonfly) has successfully completed its tender offer to purchase all outstanding shares of Dova Pharmaceuticals, Inc. (Dova) (NASDAQ: DOVA), for USD 27.50

OAKLAND, Calif., Nov. 10, 2019 /PRNewswire/ -- It is with profound sadness that we announce that Bernard J. Tyson, Chairman and CEO of Kaiser Permanente, unexpectedly passed away early today in his sleep. On behalf of our Board of Directors, employees and physicians, we extend our deepest sympathies to Bernard's family during this very

WASHINGTON, Nov. 10, 2019 /PRNewswire/ -- Today, the Lupus Foundation of America (LFA) is honored to recognize two leading lupus scientists for the significant impact they have made and continue to make in lupus research at the 2019 Evelyn V. Hess Reception, to be held this evening in Atlanta, GA during the 2019 American College of R

HOUSTON, Nov. 10, 2019 /PRNewswire/ -- Bryn Pharma, LLC ("Bryn" or the "Company"), a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to